FDA Moves To Revoke Approval Of Pig Drug Over Cancer Risks To Consumers

The FDA on April 8 moved to rescind the approval of the pig drug carbadox over concerns that it could leave cancerous residue in pork. The drug manufacturer, however, insists that carbadox is safe.